Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Progesterone effects on subjective and physiological responses to intravenous nicotine in male and female smokers.

Sofuoglu M, Mitchell E, Mooney M.

Hum Psychopharmacol. 2009 Oct;24(7):559-64. doi: 10.1002/hup.1055.

2.

Varenicline attenuates some of the subjective and physiological effects of intravenous nicotine in humans.

Sofuoglu M, Herman AI, Mooney M, Waters AJ.

Psychopharmacology (Berl). 2009 Nov;207(1):153-62. doi: 10.1007/s00213-009-1643-z. Epub 2009 Aug 20.

3.

Galantamine attenuates some of the subjective effects of intravenous nicotine and improves performance on a Go No-Go task in abstinent cigarette smokers: a preliminary report.

Sofuoglu M, Herman AI, Li Y, Waters AJ.

Psychopharmacology (Berl). 2012 Dec;224(3):413-20. doi: 10.1007/s00213-012-2763-4. Epub 2012 Jun 15.

4.

Effects of topiramate in combination with intravenous nicotine in overnight abstinent smokers.

Sofuoglu M, Poling J, Mouratidis M, Kosten T.

Psychopharmacology (Berl). 2006 Mar;184(3-4):645-51. Epub 2006 Jan 24.

PMID:
16432681
5.

Subjective responses to intravenous nicotine: greater sensitivity in women than in men.

Sofuoglu M, Mooney M.

Exp Clin Psychopharmacol. 2009 Apr;17(2):63-9. doi: 10.1037/a0015297.

6.

Effects of tiagabine in combination with intravenous nicotine in overnight abstinent smokers.

Sofuoglu M, Mouratidis M, Yoo S, Culligan K, Kosten T.

Psychopharmacology (Berl). 2005 Sep;181(3):504-10. Epub 2005 Oct 12.

PMID:
15983800
7.

Dose-related enhancement of mood and cognition in smokers administered nicotine nasal spray.

Myers CS, Taylor RC, Moolchan ET, Heishman SJ.

Neuropsychopharmacology. 2008 Feb;33(3):588-98. Epub 2007 Apr 18.

8.

Self-administration of intravenous nicotine in male and female cigarette smokers.

Sofuoglu M, Yoo S, Hill KP, Mooney M.

Neuropsychopharmacology. 2008 Mar;33(4):715-20. Epub 2007 May 30.

9.

Intravenous nicotine and caffeine: subjective and physiological effects in cocaine abusers.

Garrett BE, Griffiths RR.

J Pharmacol Exp Ther. 2001 Feb;296(2):486-94.

10.

Modafinil and nicotine interactions in abstinent smokers.

Sofuoglu M, Waters AJ, Mooney M.

Hum Psychopharmacol. 2008 Jan;23(1):21-30.

PMID:
17868195
11.

High-dose transdermal nicotine and naltrexone: effects on nicotine withdrawal, urges, smoking, and effects of smoking.

Rohsenow DJ, Monti PM, Hutchison KE, Swift RM, MacKinnon SV, Sirota AD, Kaplan GB.

Exp Clin Psychopharmacol. 2007 Feb;15(1):81-92.

PMID:
17295587
12.

Subjective and cardiovascular effects of intravenous nicotine in smokers and non-smokers.

Soria R, Stapleton JM, Gilson SF, Sampson-Cone A, Henningfield JE, London ED.

Psychopharmacology (Berl). 1996 Dec;128(3):221-6.

PMID:
8972541
13.

Increasing progesterone levels are associated with smoking abstinence among free-cycling women smokers who receive brief pharmacotherapy.

Saladin ME, McClure EA, Baker NL, Carpenter MJ, Ramakrishnan V, Hartwell KJ, Gray KM.

Nicotine Tob Res. 2015 Apr;17(4):398-406. doi: 10.1093/ntr/ntu262.

14.

Subjective and physiological effects of intravenous nicotine and cocaine in cigarette smoking cocaine abusers.

Jones HE, Garrett BE, Griffiths RR.

J Pharmacol Exp Ther. 1999 Jan;288(1):188-97.

16.

Labetalol treatment enhances the attenuation of tobacco withdrawal symptoms by nicotine in abstinent smokers.

Sofuoglu M, Babb D, Hatsukami DK.

Nicotine Tob Res. 2003 Dec;5(6):947-53.

PMID:
14668079
17.

Acute effects of nicotine and mecamylamine on tobacco withdrawal symptoms, cigarette reward and ad lib smoking.

Rose JE, Behm FM, Westman EC.

Pharmacol Biochem Behav. 2001 Feb;68(2):187-97.

PMID:
11267622
18.

Rapid nicotine clearance is associated with greater reward and heart rate increases from intravenous nicotine.

Sofuoglu M, Herman AI, Nadim H, Jatlow P.

Neuropsychopharmacology. 2012 May;37(6):1509-16. doi: 10.1038/npp.2011.336. Epub 2012 Feb 15.

19.

Effects of topiramate on cue-induced cigarette craving and the response to a smoked cigarette in briefly abstinent smokers.

Reid MS, Palamar J, Raghavan S, Flammino F.

Psychopharmacology (Berl). 2007 May;192(1):147-58. Epub 2007 Mar 8.

PMID:
17345064
20.

Minocycline reduced craving for cigarettes but did not affect smoking or intravenous nicotine responses in humans.

Sofuoglu M, Waters AJ, Mooney M, O'Malley SS.

Pharmacol Biochem Behav. 2009 Mar;92(1):135-40. doi: 10.1016/j.pbb.2008.11.004. Epub 2008 Nov 13.

Supplemental Content

Support Center